These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29740032)

  • 1. Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.
    Mellor P; Marshall JDS; Ruan X; Whitecross DE; Ross RL; Knowles MA; Moore SA; Anderson DH
    Sci Rep; 2018 May; 8(1):7108. PubMed ID: 29740032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p85alpha subunit of phosphatidylinositol 3'-kinase binds to and stimulates the GTPase activity of Rab proteins.
    Chamberlain MD; Berry TR; Pastor MC; Anderson DH
    J Biol Chem; 2004 Nov; 279(47):48607-14. PubMed ID: 15377662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of p85α Alterations in Cancer.
    Marshall JDS; Whitecross DE; Mellor P; Anderson DH
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30650664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mutations in distinct regions of p85 alpha in urothelial cancer.
    Ross RL; Burns JE; Taylor CF; Mellor P; Anderson DH; Knowles MA
    PLoS One; 2013; 8(12):e84411. PubMed ID: 24367658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking.
    Mellor P; Furber LA; Nyarko JN; Anderson DH
    Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium.
    Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB
    Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the PTEN - p85α interaction and lipid binding properties of the p85α BH domain.
    Marshall JDS; Mellor P; Ruan X; Whitecross DE; Moore SA; Anderson DH
    Oncotarget; 2018 Dec; 9(97):36975-36992. PubMed ID: 30651929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR trafficking.
    Chamberlain MD; Oberg JC; Furber LA; Poland SF; Hawrysh AD; Knafelc SM; McBride HM; Anderson DH
    Cell Signal; 2010 Oct; 22(10):1562-75. PubMed ID: 20570729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase 8 promotes peripheral localization and activation of Rab5.
    Torres VA; Mielgo A; Barilà D; Anderson DH; Stupack D
    J Biol Chem; 2008 Dec; 283(52):36280-9. PubMed ID: 18974049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Rab5 binding site in p110β: assays for PI3Kβ binding to Rab5.
    Salamon RS; Dbouk HA; Collado D; Lopiccolo J; Bresnick AR; Backer JM
    Methods Mol Biol; 2015; 1298():271-81. PubMed ID: 25800850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.
    Echeverria I; Liu Y; Gabelli SB; Amzel LM
    FEBS J; 2015 Sep; 282(18):3528-42. PubMed ID: 26122737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single discrete Rab5-binding site in phosphoinositide 3-kinase β is required for tumor cell invasion.
    Heitz SD; Hamelin DJ; Hoffmann RM; Greenberg N; Salloum G; Erami Z; Khalil BD; Shymanets A; Steidle EA; Gong GQ; Nürnberg B; Burke JE; Flanagan JU; Bresnick AR; Backer JM
    J Biol Chem; 2019 Mar; 294(12):4621-4633. PubMed ID: 30659094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab5 and Ndfip1 are involved in Pten ubiquitination and nuclear trafficking.
    Li Y; Low LH; Putz U; Goh CP; Tan SS; Howitt J
    Traffic; 2014 Jul; 15(7):749-61. PubMed ID: 24798731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.
    Cheung LW; Mills GB
    Pharmacogenomics; 2016 Feb; 17(3):297-307. PubMed ID: 26807692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of phosphatidylinositol 3-kinase composed of p110beta-catalytic and p85-regulatory subunits with the small GTPase Rab5.
    Kurosu H; Katada T
    J Biochem; 2001 Jul; 130(1):73-8. PubMed ID: 11432782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
    Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of Rab5-Rabaptin5 interaction in endocytosis.
    Zhu G; Zhai P; Liu J; Terzyan S; Li G; Zhang XC
    Nat Struct Mol Biol; 2004 Oct; 11(10):975-83. PubMed ID: 15378032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate-binding loop and Rab GTPase function: mutations at Ser29 and Ala30 of Rab5 lead to loss-of-function as well as gain-of-function phenotype.
    Li G; Liang Z
    Biochem J; 2001 May; 355(Pt 3):681-9. PubMed ID: 11311130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted RabGAP function of the p85 subunit of phosphatidylinositol 3-kinase results in cell transformation.
    Chamberlain MD; Chan T; Oberg JC; Hawrysh AD; James KM; Saxena A; Xiang J; Anderson DH
    J Biol Chem; 2008 Jun; 283(23):15861-8. PubMed ID: 18387942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.